TY - JOUR
T1 - Intertrochanteric hip fractures treated with the trochanteric fixation nail and sliding hip screw.
AU - Gill, J. Brian
AU - Jensen, Layne
AU - Chin, Paul C.
AU - Rafiei, Poyan
AU - Reddy, Kartheek
AU - Schutt, Robert C.
PY - 2007
Y1 - 2007
N2 - The primary treatment options for intertrochanteric hip fractures are a sliding hip screw (SHS) and an intramedullary device, with each having its own advantages and disadvantages. The authors retrospectively compared all intertrochanteric hip fractures between 2003 and 2005 using a cephalomedullary nail--the trochanteric fixation nail (TFN)--to those using a SHS. Outcome measures included the following parameters: age, gender, fracture classification, operation time, blood loss, transfusions, complications, follow-up, length of stay, and hospital cost. A total of 95 patients were included in the study (51 SHS and 44 TFN). The two groups were similar in age (p = .52), blood loss (p = .20), follow-up (p = .13), length of stay (p = .63), and hospital costs (p = .70). The TFN procedure required shorter operative times (56.5 min, p < .004) and was used in more complex fracture patterns (p < .03). The SHS group had fewer blood transfusions (1.2 units, p < .0008). The SHS group had a higher complication rate of 19.6%, versus the TFN group's 11.4% rate (p = .13). The TFN is an appropriate and acceptable treatment method for intertrochanteric hip fractures.
AB - The primary treatment options for intertrochanteric hip fractures are a sliding hip screw (SHS) and an intramedullary device, with each having its own advantages and disadvantages. The authors retrospectively compared all intertrochanteric hip fractures between 2003 and 2005 using a cephalomedullary nail--the trochanteric fixation nail (TFN)--to those using a SHS. Outcome measures included the following parameters: age, gender, fracture classification, operation time, blood loss, transfusions, complications, follow-up, length of stay, and hospital cost. A total of 95 patients were included in the study (51 SHS and 44 TFN). The two groups were similar in age (p = .52), blood loss (p = .20), follow-up (p = .13), length of stay (p = .63), and hospital costs (p = .70). The TFN procedure required shorter operative times (56.5 min, p < .004) and was used in more complex fracture patterns (p < .03). The SHS group had fewer blood transfusions (1.2 units, p < .0008). The SHS group had a higher complication rate of 19.6%, versus the TFN group's 11.4% rate (p = .13). The TFN is an appropriate and acceptable treatment method for intertrochanteric hip fractures.
UR - http://www.scopus.com/inward/record.url?scp=34547481347&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=34547481347&partnerID=8YFLogxK
M3 - Article
C2 - 17592712
AN - SCOPUS:34547481347
SN - 1548-825X
VL - 16
SP - 62
EP - 66
JO - Journal of surgical orthopaedic advances
JF - Journal of surgical orthopaedic advances
IS - 2
ER -